Literature DB >> 15812215

Importance of magnesium in absorption and excretion of oxalate.

Diana J Zimmermann1, Susanne Voss, Gerd E von Unruh, Albrecht Hesse.   

Abstract

INTRODUCTION: Magnesium treatment for calcium oxalate urolithiasis is discussed controversially. The aim of this study was to investigate the influence of magnesium supplementation on the oxalate absorption.
MATERIALS AND METHODS: The [13C2]oxalate absorption test was always performed three times in 6 healthy volunteers under standardized conditions, with one 10-mmol magnesium supplement together with the labeled oxalate and with two 10-mmol magnesium supplements given in 12-hour intervals.
RESULTS: The mean intestinal oxalate absorption under standard conditions was 8.6 +/- 2.83%. The oxalate absorption with one 10-mmol magnesium supplement was 5.2 +/- 1.40% and with two supplements 5.5 +/- 1.62%. Both decreases were statistically significant relative to the standard test, however, not significantly different from each other.
CONCLUSIONS: The results show that magnesium administration decreases the oxalate absorption, when magnesium is taken together with oxalate. However, magnesium administration does not decrease the oxalate absorption, when magnesium and oxalate intake differ by 12 h. Copyright 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15812215     DOI: 10.1159/000083560

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  12 in total

1.  Influence of a high-oxalate diet on intestinal oxalate absorption.

Authors:  Diana J Zimmermann; Albrecht Hesse; Gerd E von Unruh
Journal:  World J Urol       Date:  2005-11-05       Impact factor: 4.226

2.  Oxalate nephropathy from cashew nut intake.

Authors:  Margarida Bernardino; Malvinder S Parmar
Journal:  CMAJ       Date:  2016-12-12       Impact factor: 8.262

3.  Hyperoxaluria-induced tubular ischemia: the effects of verapamil and vitamin E on apoptotic changes with an emphasis on renal papilla in rat model.

Authors:  Orhan Tanriverdi; Dilek Telci; Mustafa Aydin; Işın Dogan Ekici; Cengiz Miroglu; Kemal Sarıca
Journal:  Urol Res       Date:  2011-05-24

4.  Bioavailability of magnesium from different pharmaceutical formulations.

Authors:  Roswitha Siener; Andrea Jahnen; Albrecht Hesse
Journal:  Urol Res       Date:  2010-09-23

Review 5.  Nephropathy in dietary hyperoxaluria: A potentially preventable acute or chronic kidney disease.

Authors:  Robert H Glew; Yijuan Sun; Bruce L Horowitz; Konstantin N Konstantinov; Marc Barry; Joanna R Fair; Larry Massie; Antonios H Tzamaloukas
Journal:  World J Nephrol       Date:  2014-11-06

Review 6.  [Calcium oxalate stones and hyperoxaluria. What is certain? What is new?].

Authors:  M Straub; R E Hautmann; A Hesse; L Rinnab
Journal:  Urologe A       Date:  2005-11       Impact factor: 0.639

7.  Educational review: role of the pediatric nephrologists in the work-up and management of kidney stones.

Authors:  Carmen Inés Rodriguez Cuellar; Peter Zhan Tao Wang; Michael Freundlich; Guido Filler
Journal:  Pediatr Nephrol       Date:  2019-01-04       Impact factor: 3.714

8.  Mechanism of urinary calcium regulation by urinary magnesium and pH.

Authors:  Olivier Bonny; Adam Rubin; Chou-Long Huang; William H Frawley; Charles Y C Pak; Orson W Moe
Journal:  J Am Soc Nephrol       Date:  2008-04-30       Impact factor: 10.121

Review 9.  The management of patients with enteric hyperoxaluria.

Authors:  John R Asplin
Journal:  Urolithiasis       Date:  2015-12-08       Impact factor: 3.436

Review 10.  Oxalate nephropathy in systemic sclerosis: Case series and review of the literature.

Authors:  Colin B Ligon; Laura K Hummers; Zsuzsanna H McMahan
Journal:  Semin Arthritis Rheum       Date:  2015-07-02       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.